<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=NQO2</id>
	<title>NQO2 - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=NQO2"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=NQO2&amp;action=history"/>
	<updated>2026-05-15T19:37:02Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=NQO2&amp;diff=4446&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «Ribosyldihydronicotinamide dehydrogenase [quinone] (EC 1.10.5.1) (NRH dehydrogenase [quinone] 2) (NRH:quinone oxidoreductase 2) (Quinone reductase 2) (QR2) [NMOR2...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=NQO2&amp;diff=4446&amp;oldid=prev"/>
		<updated>2021-04-29T19:18:34Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «Ribosyldihydronicotinamide dehydrogenase [quinone] (EC 1.10.5.1) (NRH dehydrogenase [quinone] 2) (NRH:quinone oxidoreductase 2) (Quinone reductase 2) (QR2) [NMOR2...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Ribosyldihydronicotinamide dehydrogenase [quinone] (EC 1.10.5.1) (NRH dehydrogenase [quinone] 2) (NRH:quinone oxidoreductase 2) (Quinone reductase 2) (QR2) [NMOR2]&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=The ontogeny and population variability of human hepatic dihydronicotinamide riboside:quinone oxidoreductase ([[NQO2]]).&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28346733&lt;br /&gt;
|abstract=Dihydronicotinamide riboside:quinone oxidoreductase ([[NQO2]]) is an enzyme that performs reduction reactions involved in antioxidant defense. We hypothesized that [[NQO2]] hepatic drug clearance would develop in children over time, similar to [[NQO1]]. Using human liver cytosol (n = 117), the effects of age, sex, ethnicity, and weight on [[NQO2]] expression and activity were probed. No significant correlations were observed. Biochemical activity of [[NQO2]] was as high at birth as in adults (0.23 ± 0.04 nmol/min/mg protein, mean ± SEM, range 0-1.83). In contrast, modeled hepatic clearance through the [[NQO2]] pathway was up to 10% of adult levels at birth, reaching predicted adult levels (0.3 ± 0.03 L/h) at 14 years of age. Comparisons between [[NQO1]] and [[NQO2]] in the same livers showed that neither protein (P = 0.32) nor activity (P = 0.23) correlated, confirming both orthologs are independently regulated. Because hepatic clearance through [[NQO2]] does not mature until teenage years, compounds detoxified by this enzyme may be more deleterious in children.&lt;br /&gt;
|mesh-terms=* Aging&lt;br /&gt;
* Female&lt;br /&gt;
* Humans&lt;br /&gt;
* Liver&lt;br /&gt;
* Male&lt;br /&gt;
* NAD(P)H Dehydrogenase (Quinone)&lt;br /&gt;
* Quinone Reductases&lt;br /&gt;
|keywords=* antioxidants&lt;br /&gt;
* drug metabolism&lt;br /&gt;
* in vitro-in vivo extrapolation&lt;br /&gt;
* pediatric&lt;br /&gt;
* physiologically based pharmacokinetic modeling&lt;br /&gt;
|full-text-url=https://sci-hub.do/10.1002/jbt.21921&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>